Few things worry regulators more than late or incomplete safety reporting. In India, the New Drugs and Clinical Trials Rules, 2019 set clear timelines for serious adverse events (SAEs) – and missing them is one of the most frequent findings in audits and inspections.
This post is general guidance; always confirm against the current Rules and CDSCO guidance.
What counts as an SAE?
An adverse event is serious if it results in death, is life-threatening, requires or prolongs hospitalisation, causes persistent or significant disability, or results in a congenital anomaly – or is otherwise considered medically important.
The key timelines
- Within 24 hours of becoming aware: the investigator reports the SAE to the Central Licensing Authority, the sponsor and the Ethics Committee.
- Within 14 days: a detailed report with analysis, including causality, is submitted.
The Ethics Committee and the licensing authority then review the event, including whether it is related to the trial and whether compensation applies.
Where things go wrong
- Delayed awareness. Participants are admitted to another hospital and the site learns about it days later.
- Weekend and holiday gaps. The PI is unavailable and no backup is named.
- Incomplete initial reports. The 24-hour report is delayed while waiting for full information. Report what you know – follow-up can come later.
- Causality not documented. The investigator's assessment of relatedness is missing or unsigned.
- Different clocks. Global sponsor processes based on other countries' timelines are not adjusted for India.
- Poor reconciliation. SAEs in the safety database don't match those in the clinical database.
Practical steps for sites
- Give every participant a card with 24-hour contact numbers and instructions to inform the site of any hospital visit.
- Name a backup investigator for reporting when the PI is away.
- Keep reporting forms and contact details ready in one place.
- Record the date and time of awareness clearly – the clock starts there.
- Track every SAE through to resolution in an SAE log.
Practical steps for sponsors
- Make sure your safety management plan reflects Indian timelines.
- Train sites at initiation and re-train after any late report.
- Monitor SAE reporting timeliness as a key risk indicator.
- Perform regular reconciliation between the safety and clinical databases.
- Audit safety processes at high-risk sites.
Why it matters
Timely SAE reporting protects participants first and foremost. It also determines whether compensation decisions can be made fairly and on time – an area that regulators and the public watch closely in India.
Want an independent review of safety reporting at your sites? Write to me at anup.cra@gmail.com.
– Anup Kumar, Independent Clinical Research Auditor & Consultant, New Delhi
No comments:
Post a Comment